Annual Revenue
$787.65 M
+$200.28 M+34.10%
31 December 2023
Summary:
Ionis Pharmaceuticals annual revenue is currently $787.65 million, with the most recent change of +$200.28 million (+34.10%) on 31 December 2023. During the last 3 years, it has risen by +$58.38 million (+8.01%). IONS annual revenue is now -29.84% below its all-time high of $1.12 billion, reached on 31 December 2019.IONS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$133.81 M
-$91.44 M-40.59%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly revenue is currently $133.81 million, with the most recent change of -$91.44 million (-40.59%) on 30 September 2024. Over the past year, it has dropped by -$10.39 million (-7.21%). IONS quarterly revenue is now -72.89% below its all-time high of $493.68 million, reached on 31 December 2019.IONS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$803.07 M
-$10.39 M-1.28%
30 September 2024
Summary:
Ionis Pharmaceuticals TTM revenue is currently $803.07 million, with the most recent change of -$10.39 million (-1.28%) on 30 September 2024. Over the past year, it has increased by +$188.03 million (+30.57%). IONS TTM revenue is now -28.46% below its all-time high of $1.12 billion, reached on 31 December 2019.IONS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.1% | -7.2% | +30.6% |
| 3 y3 years | +8.0% | +0.5% | +21.5% |
| 5 y5 years | +31.4% | -20.3% | -2.2% |
IONS Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2.8% | +34.1% | -69.6% | +12.0% | -8.3% | +39.4% |
| 5 y | 5 years | -29.8% | +34.1% | -72.9% | +19.9% | -28.5% | +39.4% |
| alltime | all time | -29.8% | >+9999.0% | -72.9% | +6790.7% | -28.5% | >+9999.0% |
Ionis Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $133.81 M(-40.6%) | $803.07 M(-1.3%) |
| June 2024 | - | $225.25 M(+88.5%) | $813.46 M(+4.7%) |
| Mar 2024 | - | $119.50 M(-63.2%) | $776.62 M(-1.4%) |
| Dec 2023 | $787.65 M(+34.1%) | $324.50 M(+125.0%) | $787.65 M(+28.1%) |
| Sept 2023 | - | $144.21 M(-23.5%) | $615.03 M(-2.5%) |
| June 2023 | - | $188.41 M(+44.3%) | $630.59 M(+9.5%) |
| Mar 2023 | - | $130.52 M(-14.1%) | $575.97 M(-1.9%) |
| Dec 2022 | $587.37 M(-27.5%) | $151.89 M(-4.9%) | $587.37 M(-32.9%) |
| Sept 2022 | - | $159.77 M(+19.4%) | $875.48 M(+3.1%) |
| June 2022 | - | $133.79 M(-5.7%) | $848.81 M(+1.0%) |
| Mar 2022 | - | $141.92 M(-67.7%) | $840.77 M(+3.7%) |
| Dec 2021 | $810.46 M(+11.1%) | $440.01 M(+230.6%) | $810.46 M(+22.7%) |
| Sept 2021 | - | $133.09 M(+5.8%) | $660.73 M(-3.9%) |
| June 2021 | - | $125.75 M(+12.7%) | $687.72 M(-2.8%) |
| Mar 2021 | - | $111.61 M(-61.6%) | $707.50 M(-3.0%) |
| Dec 2020 | $729.26 M(-35.0%) | $290.28 M(+81.3%) | $729.26 M(-21.8%) |
| Sept 2020 | - | $160.08 M(+10.0%) | $932.66 M(-0.8%) |
| June 2020 | - | $145.54 M(+9.1%) | $940.48 M(-1.9%) |
| Mar 2020 | - | $133.37 M(-73.0%) | $958.75 M(-14.6%) |
| Dec 2019 | $1.12 B(+87.2%) | $493.68 M(+194.0%) | $1.12 B(+36.7%) |
| Sept 2019 | - | $167.89 M(+2.5%) | $821.03 M(+2.8%) |
| June 2019 | - | $163.81 M(-44.9%) | $798.54 M(+6.1%) |
| Mar 2019 | - | $297.21 M(+54.7%) | $752.47 M(+25.5%) |
| Dec 2018 | $599.67 M(+16.6%) | $192.12 M(+32.1%) | $599.68 M(+4.2%) |
| Sept 2018 | - | $145.40 M(+23.5%) | $575.35 M(+4.9%) |
| June 2018 | - | $117.75 M(-18.5%) | $548.27 M(+1.0%) |
| Mar 2018 | - | $144.42 M(-13.9%) | $542.80 M(+5.6%) |
| Dec 2017 | $514.18 M(+37.9%) | $167.79 M(+41.8%) | $514.18 M(-3.5%) |
| Sept 2017 | - | $118.31 M(+5.4%) | $532.89 M(+1.4%) |
| June 2017 | - | $112.27 M(-3.0%) | $525.50 M(+16.3%) |
| Mar 2017 | - | $115.80 M(-37.9%) | $451.70 M(+21.2%) |
| Dec 2016 | $372.78 M(+31.4%) | $186.50 M(+68.1%) | $372.77 M(+56.7%) |
| Sept 2016 | - | $110.93 M(+188.3%) | $237.84 M(+35.1%) |
| June 2016 | - | $38.47 M(+4.3%) | $176.03 M(-31.8%) |
| Mar 2016 | - | $36.87 M(-28.5%) | $257.99 M(-9.1%) |
| Dec 2015 | $283.70 M(+32.5%) | $51.57 M(+5.0%) | $283.70 M(-10.5%) |
| Sept 2015 | - | $49.12 M(-59.2%) | $316.99 M(+1.6%) |
| June 2015 | - | $120.43 M(+92.4%) | $311.94 M(+25.5%) |
| Mar 2015 | - | $62.58 M(-26.3%) | $248.58 M(+16.1%) |
| Dec 2014 | $214.16 M(+45.4%) | $84.86 M(+92.6%) | $214.16 M(+24.8%) |
| Sept 2014 | - | $44.06 M(-22.8%) | $171.55 M(+13.6%) |
| June 2014 | - | $57.08 M(+102.7%) | $151.07 M(+14.4%) |
| Mar 2014 | - | $28.16 M(-33.3%) | $132.09 M(-10.3%) |
| Dec 2013 | $147.28 M(+44.3%) | $42.25 M(+79.1%) | $147.29 M(+17.9%) |
| Sept 2013 | - | $23.59 M(-38.1%) | $124.91 M(+10.6%) |
| June 2013 | - | $38.09 M(-12.1%) | $112.93 M(-7.6%) |
| Mar 2013 | - | $43.36 M(+118.2%) | $122.17 M(+19.7%) |
| Dec 2012 | $102.05 M(+3.0%) | $19.87 M(+71.3%) | $102.05 M(-10.9%) |
| Sept 2012 | - | $11.60 M(-75.5%) | $114.58 M(-7.4%) |
| June 2012 | - | $47.34 M(+103.7%) | $123.69 M(+22.3%) |
| Mar 2012 | - | $23.23 M(-28.3%) | $101.17 M(+2.1%) |
| Dec 2011 | $99.09 M(-8.7%) | $32.40 M(+56.4%) | $99.09 M(+6.4%) |
| Sept 2011 | - | $20.71 M(-16.6%) | $93.10 M(-7.8%) |
| June 2011 | - | $24.82 M(+17.4%) | $101.01 M(+1.3%) |
| Mar 2011 | - | $21.15 M(-20.0%) | $99.69 M(-8.1%) |
| Dec 2010 | $108.47 M(-10.8%) | $26.42 M(-7.7%) | $108.47 M(-5.1%) |
| Sept 2010 | - | $28.62 M(+21.8%) | $114.31 M(+1.6%) |
| June 2010 | - | $23.50 M(-21.5%) | $112.46 M(-6.2%) |
| Mar 2010 | - | $29.93 M(-7.2%) | $119.95 M(-1.4%) |
| Dec 2009 | $121.60 M(+13.4%) | $32.26 M(+20.5%) | $121.60 M(+2.2%) |
| Sept 2009 | - | $26.77 M(-13.6%) | $118.99 M(-2.2%) |
| June 2009 | - | $30.99 M(-1.8%) | $121.68 M(+1.1%) |
| Mar 2009 | - | $31.58 M(+6.5%) | $120.39 M(+12.3%) |
| Dec 2008 | $107.19 M(+83.7%) | $29.65 M(+0.6%) | $107.19 M(+17.8%) |
| Sept 2008 | - | $29.46 M(-0.8%) | $90.99 M(-9.2%) |
| June 2008 | - | $29.70 M(+61.6%) | $100.16 M(+34.9%) |
| Mar 2008 | - | $18.38 M(+36.6%) | $74.27 M(+27.3%) |
| Dec 2007 | $58.34 M | $13.45 M(-65.2%) | $58.34 M(+23.7%) |
| Sept 2007 | - | $38.63 M(+913.1%) | $47.17 M(+300.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | $3.81 M(+55.6%) | $11.79 M(-4.6%) |
| Mar 2007 | - | $2.45 M(+7.8%) | $12.35 M(-16.9%) |
| Dec 2006 | $14.86 M(-63.0%) | $2.27 M(-30.2%) | $14.86 M(-45.4%) |
| Sept 2006 | - | $3.25 M(-25.6%) | $27.23 M(-13.4%) |
| June 2006 | - | $4.38 M(-11.8%) | $31.43 M(-16.5%) |
| Mar 2006 | - | $4.96 M(-66.1%) | $37.65 M(-6.2%) |
| Dec 2005 | $40.13 M(-5.8%) | $14.64 M(+96.3%) | $40.13 M(+8.8%) |
| Sept 2005 | - | $7.46 M(-29.6%) | $36.88 M(-4.2%) |
| June 2005 | - | $10.59 M(+42.3%) | $38.51 M(+2.0%) |
| Mar 2005 | - | $7.44 M(-34.6%) | $37.76 M(-11.4%) |
| Dec 2004 | $42.62 M(-14.7%) | $11.38 M(+25.2%) | $42.62 M(+4.1%) |
| Sept 2004 | - | $9.09 M(-7.6%) | $40.94 M(-5.1%) |
| June 2004 | - | $9.84 M(-20.0%) | $43.14 M(-10.7%) |
| Mar 2004 | - | $12.30 M(+26.8%) | $48.31 M(-3.4%) |
| Dec 2003 | $49.99 M(-37.7%) | $9.70 M(-14.1%) | $49.99 M(-19.6%) |
| Sept 2003 | - | $11.29 M(-24.8%) | $62.15 M(-12.7%) |
| June 2003 | - | $15.02 M(+7.4%) | $71.16 M(-6.6%) |
| Mar 2003 | - | $13.98 M(-36.0%) | $76.20 M(-5.0%) |
| Dec 2002 | $80.18 M(+50.5%) | $21.86 M(+7.7%) | $80.18 M(+0.1%) |
| Sept 2002 | - | $20.30 M(+1.2%) | $80.06 M(+1.3%) |
| June 2002 | - | $20.06 M(+11.7%) | $79.07 M(+18.7%) |
| Mar 2002 | - | $17.96 M(-17.4%) | $66.60 M(+25.0%) |
| Dec 2001 | $53.27 M(+43.0%) | $21.74 M(+12.6%) | $53.27 M(+35.0%) |
| Sept 2001 | - | $19.30 M(+154.3%) | $39.47 M(+2.7%) |
| June 2001 | - | $7.59 M(+63.9%) | $38.44 M(+1.6%) |
| Mar 2001 | - | $4.63 M(-41.6%) | $37.83 M(+1.6%) |
| Dec 2000 | $37.26 M(+9.9%) | $7.94 M(-56.6%) | $37.26 M(-4.0%) |
| Sept 2000 | - | $18.28 M(+161.7%) | $38.82 M(+24.7%) |
| June 2000 | - | $6.99 M(+72.3%) | $31.14 M(-0.7%) |
| Mar 2000 | - | $4.05 M(-57.3%) | $31.35 M(-7.5%) |
| Dec 1999 | $33.90 M(-13.5%) | $9.50 M(-10.4%) | $33.90 M(+5.6%) |
| Sept 1999 | - | $10.60 M(+47.2%) | $32.10 M(-22.5%) |
| June 1999 | - | $7.20 M(+9.1%) | $41.40 M(+3.5%) |
| Mar 1999 | - | $6.60 M(-14.3%) | $40.00 M(+2.0%) |
| Dec 1998 | $39.20 M(+19.9%) | $7.70 M(-61.3%) | $39.20 M(-4.6%) |
| Sept 1998 | - | $19.90 M(+243.1%) | $41.10 M(+21.6%) |
| June 1998 | - | $5.80 M(0.0%) | $33.80 M(0.0%) |
| Mar 1998 | - | $5.80 M(-39.6%) | $33.80 M(+3.7%) |
| Dec 1997 | $32.70 M(+44.1%) | $9.60 M(-23.8%) | $32.60 M(+10.5%) |
| Sept 1997 | - | $12.60 M(+117.2%) | $29.50 M(+34.1%) |
| June 1997 | - | $5.80 M(+26.1%) | $22.00 M(+5.3%) |
| Mar 1997 | - | $4.60 M(-29.2%) | $20.90 M(-7.9%) |
| Dec 1996 | $22.70 M(+74.6%) | $6.50 M(+27.5%) | $22.70 M(+15.8%) |
| Sept 1996 | - | $5.10 M(+8.5%) | $19.60 M(+7.7%) |
| June 1996 | - | $4.70 M(-26.6%) | $18.20 M(+8.3%) |
| Mar 1996 | - | $6.40 M(+88.2%) | $16.80 M(+29.2%) |
| Dec 1995 | $13.00 M(+28.7%) | $3.40 M(-8.1%) | $13.00 M(+71.1%) |
| Sept 1995 | - | $3.70 M(+12.1%) | $7.60 M(+7.0%) |
| June 1995 | - | $3.30 M(+26.9%) | $7.10 M(+2.9%) |
| Mar 1995 | - | $2.60 M(-230.0%) | $6.90 M(0.0%) |
| Dec 1994 | $10.10 M(-16.5%) | -$2.00 M(-162.5%) | $6.90 M(-41.5%) |
| Sept 1994 | - | $3.20 M(+3.2%) | $11.80 M(-0.8%) |
| June 1994 | - | $3.10 M(+19.2%) | $11.90 M(-0.8%) |
| Mar 1994 | - | $2.60 M(-10.3%) | $12.00 M(-0.8%) |
| Dec 1993 | $12.10 M(+39.1%) | $2.90 M(-12.1%) | $12.10 M(+23.5%) |
| Sept 1993 | - | $3.30 M(+3.1%) | $9.80 M(0.0%) |
| June 1993 | - | $3.20 M(+18.5%) | $9.80 M(+10.1%) |
| Mar 1993 | - | $2.70 M(+350.0%) | $8.90 M(+2.3%) |
| Dec 1992 | $8.70 M(+38.1%) | $600.00 K(-81.8%) | $8.70 M(-2.2%) |
| Sept 1992 | - | $3.30 M(+43.5%) | $8.90 M(+17.1%) |
| June 1992 | - | $2.30 M(-8.0%) | $7.60 M(+11.8%) |
| Mar 1992 | - | $2.50 M(+212.5%) | $6.80 M(+17.2%) |
| Dec 1991 | $6.30 M(+215.0%) | $800.00 K(-60.0%) | $5.80 M(+5.5%) |
| Sept 1991 | - | $2.00 M(+33.3%) | $5.50 M(+37.5%) |
| June 1991 | - | $1.50 M(0.0%) | $4.00 M(+33.3%) |
| Mar 1991 | - | $1.50 M(+200.0%) | $3.00 M(+50.0%) |
| Dec 1990 | $2.00 M | $500.00 K(0.0%) | $2.00 M(+33.3%) |
| Sept 1990 | - | $500.00 K(0.0%) | $1.50 M(+50.0%) |
| June 1990 | - | $500.00 K(0.0%) | $1.00 M(+100.0%) |
| Mar 1990 | - | $500.00 K | $500.00 K |
FAQ
- What is Ionis Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual revenue year-on-year change?
- What is Ionis Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly revenue year-on-year change?
- What is Ionis Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM revenue year-on-year change?
What is Ionis Pharmaceuticals annual revenue?
The current annual revenue of IONS is $787.65 M
What is the all time high annual revenue for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual revenue is $1.12 B
What is Ionis Pharmaceuticals annual revenue year-on-year change?
Over the past year, IONS annual revenue has changed by +$200.28 M (+34.10%)
What is Ionis Pharmaceuticals quarterly revenue?
The current quarterly revenue of IONS is $133.81 M
What is the all time high quarterly revenue for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly revenue is $493.68 M
What is Ionis Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, IONS quarterly revenue has changed by -$10.39 M (-7.21%)
What is Ionis Pharmaceuticals TTM revenue?
The current TTM revenue of IONS is $803.07 M
What is the all time high TTM revenue for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM revenue is $1.12 B
What is Ionis Pharmaceuticals TTM revenue year-on-year change?
Over the past year, IONS TTM revenue has changed by +$188.03 M (+30.57%)